Works matching IS 03128008 AND DT 2022 AND VI 45 AND IP 2


Results: 14
    1
    2

    Fostemsavir.

    Published in:
    Australian Prescriber, 2022, v. 45, n. 2, p. 63, doi. 10.18773/austprescr.2022.016
    Publication type:
    Article
    3

    Ravulizumab.

    Published in:
    Australian Prescriber, 2022, v. 45, n. 2, p. 66, doi. 10.18773/austprescr.2022.018
    Publication type:
    Article
    4

    Lanadelumab.

    Published in:
    Australian Prescriber, 2022, v. 45, n. 2, p. 65, doi. 10.18773/austprescr.2022.017
    Publication type:
    Article
    5
    6

    Nirmatrelvir and ritonavir.

    Published in:
    Australian Prescriber, 2022, v. 45, n. 2, p. 61, doi. 10.18773/austprescr.2022.015
    Publication type:
    Article
    7

    Molnupiravir.

    Published in:
    Australian Prescriber, 2022, v. 45, n. 2, p. 60, doi. 10.18773/austprescr.2022.014
    Publication type:
    Article
    8

    Casirivimab and imdevimab.

    Published in:
    Australian Prescriber, 2022, v. 45, n. 2, p. 58, doi. 10.18773/austprescr.2022.013
    Publication type:
    Article
    9
    10

    Antidepressants in adolescence.

    Published in:
    Australian Prescriber, 2022, v. 45, n. 2, p. 49, doi. 10.18773/austprescr.2022.011
    By:
    • Hazell, Philip
    Publication type:
    Article
    11
    12

    Statin doses after acute coronary syndrome.

    Published in:
    Australian Prescriber, 2022, v. 45, n. 2, p. 42, doi. 10.18773/austprescr.2022.020
    By:
    • Dimmitt, Simon B.;
    • Martin, Jennifer H.;
    • Eng-Frost, Joanne;
    • Chew, Derek
    Publication type:
    Article
    13
    14